ReviewBioengineering (Basel, Switzerland)2026
3D Printing for Pelvic Organ Prolapse Management: A Narrative Review of Emerging Applications.
Review in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Pelvic organ prolapse (POP) is a common benign gynecological disorder that substantially affects quality of life, particularly in aging female populations. Current management strategies, including standardized vaginal pessaries and synthetic surgical meshes, are often limited by poor anatomical adaptability, mechanical mismatch with native pelvic tissues, and long-term safety concerns. These limitations have driven increasing interest in personalized and biomechanically compatible therapeutic solutions. Three-dimensional (3D) printing, also known as additive manufacturing, has emerged as a promising bioengineering technology to address these unmet clinical needs. By enabling layer-by-layer fabrication directly from digital models, 3D printing allows for precise control over device geometry, mechanical properties, and material composition, facilitating patient-specific design. This narrative review summarizes recent progress in 3D printing for POP management across three major application domains: (i) next-generation meshes based on biodegradable polymers, elastomeric materials, natural biomaterials, and hydrogel systems; (ii) customized vaginal pessaries tailored to individual pelvic anatomy using imaging-assisted workflows; and (iii) imaging-based pelvic models and prototype devices for surgical planning, education, and exploratory assessment. Overall, existing studies demonstrate that 3D printing enables improved biomechanical compatibility, enhanced tissue integration, and multifunctional device design, including drug delivery capability. Although current evidence is largely pre-clinical or based on pilot studies, additive manufacturing holds strong potential to advance POP management toward safer, personalized, and functionally optimized clinical solutions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.